MELISSA MCLENON: Open Payments
NPI 1801887179 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,722 in 34 payments from 12 companies in 2025. Trend: 2023 $1,782 · 2024 $4,334 · 2025 $2,722
Food & beverage: $2,722
| Company | Payments | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 3 | $463 |
| Actelion Pharmaceuticals US, Inc. | 11 | $425 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $375 |
| Impulse Dynamics (USA) Inc. | 4 | $330 |
| ABIOMED | 3 | $279 |
| CVRx, Inc. | 1 | $171 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $141 |
| Abbott Laboratories | 1 | $136 |
| Mallinckrodt Hospital Products Inc. | 1 | $127 |
| Alnylam Pharmaceuticals Inc. | 1 | $126 |
Products named: Assure WCD, UPTRAVI, JARDIANCE, Optimizer, Barostim Neo System, LifeVest, CARDIOMEMS, ACTHAR.
Industry payments across CA — which companies pay providers there.
